CIK 0000818033 · Accelerated filer
HERON THERAPEUTICS, INC. /DE/
Sign in to watch- Ticker
- HRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 942875566
- Phone
- 8582514400
- Business address
- 4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-10-13 | Peraza Lisa VP, Chief Accounting Officer | Option exercise | +1,932 | 55,682 | ||
| 2023-10-13 | Peraza Lisa VP, Chief Accounting Officer | Shares withheld for taxes | −860 | $0.72 | $619 | 54,822 |
| 2023-10-13 | Peraza Lisa VP, Chief Accounting Officer | Option exercise · Restricted Stock Units | −552 | 2,208 | ||
| 2023-10-13 | Peraza Lisa VP, Chief Accounting Officer | Option exercise · Restricted Stock Units | −1,932 | 7,964 | ||
| 2023-08-22 | Collard Craig A Chief Executive Officer | Shares withheld for taxes | −692 | $1.65 | $1K | 36,496 |
| 2023-07-25 | Peraza Lisa VP, Chief Accounting Officer | Option exercise | +42,631 | 67,941 | ||
| 2023-07-25 | Peraza Lisa VP, Chief Accounting Officer | Shares withheld for taxes | −14,743 | $1.51 | $22K | 53,198 |
| 2023-07-25 | Peraza Lisa VP, Chief Accounting Officer | Option exercise · Performance Stock Units | −42,631 | 0 | ||
| 2023-07-21 | Morgan Adam Director | Purchase | +2,486,744 | $1.37 | $3.4M | 6,986,744 |
| 2023-07-21 | Morgan Adam Director | Purchase · Pre-funded Warrants to Purchase Common Stock | +1,162,891 | $1.37 | $1.6M | 1,162,891 |
| 2023-07-17 | Peraza Lisa VP, Chief Accounting Officer | Grant or award · Employee Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2023-07-13 | Szekeres David Leslie EVP, Chief Operating Officer | Option exercise | +1,250 | 31,202 | ||
| 2023-07-13 | Szekeres David Leslie EVP, Chief Operating Officer | Option exercise | +4,564 | 35,766 | ||
| 2023-07-13 | Szekeres David Leslie EVP, Chief Operating Officer | Shares withheld for taxes | −2,012 | $1.31 | $3K | 33,754 |
| 2023-07-13 | Szekeres David Leslie EVP, Chief Operating Officer | Option exercise · Restricted Stock Units | −1,250 | 6,250 | ||
| 2023-07-13 | Szekeres David Leslie EVP, Chief Operating Officer | Option exercise · Restricted Stock Units | −4,564 | 23,372 | ||
| 2023-07-13 | Peraza Lisa VP, Chief Accounting Officer | Option exercise | +552 | 24,237 | ||
| 2023-07-13 | Peraza Lisa VP, Chief Accounting Officer | Option exercise | +1,933 | 26,170 | ||
| 2023-07-13 | Peraza Lisa VP, Chief Accounting Officer | Shares withheld for taxes | −860 | $1.31 | $1K | 25,310 |
| 2023-07-13 | Peraza Lisa VP, Chief Accounting Officer | Option exercise · Restricted Stock Units | −552 | 2,760 |
Page 14 of 28 · 557 trades